Skip to main content

NICE supports age discrimination

From the National Institute for Health and Clinical Excellence (see link)

Draft proposals for health rationing.
Recommendation 6
With respect to age (section 5.1):
• however, where age is an indicator of benefit or risk, age discrimination
is appropriate.

Recommendation 7
When setting priorities there is no case for discrimination on the basis of
gender or sexual orientation unless these are risk factors for benefits, risks, or
both (section 5.2).

Recommendation 14
Priority for patients with conditions associated with social stigma should only
be considered if the additional psychological burdens have not been
adequately taken into account in the cost–utility analyses (section 6.5).


The above recommendations raise a number of issues, not least the question as to exactly when "age discrimination is appropriate". I can understand the risk issue, but the benefit issue is not clear.

What I have difficulty understanding is what "risk factors for benefits, risks or both" exist for gender or sexual orientation discrimination.

Perhaps the most significant is, however:
Recommendation 5
NICE guidance should explain, explicitly, reasons for recommending – as cost
effective – those interventions with an incremental cost-effectiveness ratio
over £20,000 to £30,000 per QALY (section 4.3).


(A QALY is a Quality Adjusted Life Year).

Comments

Popular posts from this blog

Trudiagnostic change PACE leaderboard algorithm - was in position 40, now position 44 - does it matter?

Trudiagnostic have changed the way they handle the Rejuvenation Olympics Leaderboard algorithm. The result of this initially was that I was globally no 40 and have now dropped to 44. Trudiagnostic are a US company that get samples of blood and they look at the DNA to see which parts of the DNA have methyl groups (CH3) attached to them. These modifications to DNA are called methylation markers. DunedinPACE is an algorithm which uses DNA methylation markers in white blood cells to work out how quickly or slowly someone is aging. I had three results on this. The odd thing about the results was that whilst my epigenetic age calculated from the same methylation markers was going down, the speed at which I was aging was going up. I find this somewhat counterintuitive. It is, however, I think relevant that in a global contest my approach on biochemistry which is quite different to many other people's does seem to keep up with others working in the same area. To that extent it...